How much could rotavirus vaccines reduce diarrhea-associated mortality in northern Ghana? A model to assess impact

Journal of Infectious Diseases

Volumn 200, Issue SUPPL. 1, 2009, Pages

  Arvay, Melissa L ^a   Curns, Aaron T ^a   Terp, Sophia ^b   Armah, George ^d,e   Wontuo, Peter ^f   Parashar, Umesh D ^a   Binka, Fred ^e   Glass, Roger I ^c   Widdowson, Marc Alain ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d University of Ghana   (Ghana)

^e UNIVERSITY OF GHANA   (Ghana)

^f NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; PERTUSSIS VACCINE; ROTAVIRUS VACCINE; TETANUS TOXOID;

AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DIARRHEA; DIPHTHERIA; DISEASE SURVEILLANCE; DRUG EFFICACY; GHANA; MORTALITY; PERTUSSIS; PRIORITY JOURNAL; RURAL AREA; STATISTICAL MODEL; TETANUS; TREATMENT INDICATION; VACCINATION; VIRUS INFECTION;

DIARRHEA; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; GHANA; HUMANS; INFANT; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION;

EID: 72849129788     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605062     Document Type: Article

References (24)

1. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: current prospects and future challenges. Lancet 2006; 368:323-332 (Pubitemid 44067224) (Pubitemid 44067224)
2. Armah G BF, Aikins M, Anto, Damanka S. Disease burden of rotavirusassociated diarrhea and treatment in northern Ghana [abstract 098 (205)]. In: Program and abstracts of the 8th Commonwealth Congress on Diarrhoea and Malnutrition (Dhaka, Bangladesh). Dhaka, Bangladesh: International Centre for Diarrhoeal Disease Research, Bangladesh, 2006: 97.
3. Parashar UD, Gibson CJ, Bresse JS, Glass RI. Rotavirus and severe childhood diarrhea. Emerg Infect Dis 2006; 12:304-306
4. World Health Organization. Report of the meeting on future directions for rotavirus vaccine research in developing countries. Geneva: World Health Organization, 2000.
5. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006; 354:11-22. (Pubitemid 43048947) (Pubitemid 43048947)
6. Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006; 354:23-33. (Pubitemid 43048948) (Pubitemid 43048948)
7. Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD. Rotavirus vaccines: targeting the developing world. J Infect Dis 2005; 192(Suppl 1):S160-6.
8. World Health Organization. Rotavirus vaccines. Wkly Epidemiol Rec 2007; 82:285-296
9. United Nations Childrens Fund (UNICEF). At a glance: Ghana statistics. Available at: http://www.unicef.org/infobycountry/ghana-statistics.html. Accessed November 2008.
10. PATH. Partner profile: Noguchi Memorial Institute for Medical Research, Ghana. Rotavirus update: news from the Rotavirus Vaccine Program, a partnership with the US CDC and WHO. Seattle, WA: PATH, 2008.
11. Ghana Statistical Service, Noguchi Memorial Institute for Medical Research. ORC Macro. Ghana demographic and health survey. Accra, Ghana: Ghana Statistical Service, 2004.
12. Binka FN, Anto FK, Oduro AR, et al. Incidence and risk factors of paediatric rotavirus diarrhoea in northern Ghana. Trop Med Int Health 2003; 8:840-846
13. Binka FN, Maude GH, Gyapong M, Ross DA, Smith PG. Risk factors for child mortality in northern Ghana: a case-control study. Int J Epidemiol 1995; 24:127-135
14. Nyarko PW, Nazzar P, Phillips A, Ngom J, Binka P, Navrongo F. DSS Ghana. INDEPTH Monograph 2008; 1:1-13.
15. Biritwum RB, Asante A, Amoo PK, et al. Community-based cluster surveys on treatment preferences for diarrhoea, severe diarrhoea, and dysentery in children aged less than five years in two districts of Ghana. J Health Popul Nutr 2004; 22:182-190 (Pubitemid 39199664)
16. Cunliffe NA, Kilgore PE, Bresee JS, et al. Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ 1998; 76:525-537
17. United Nations Childrens Fund (UNICEF). WHO/UNICEF review ofnational immunization coverage 1980-2007-Ghana. New York: UNICEF, 2008:1-12.
18. Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics 2007; 119:684-697 (Pubitemid 46556667) (Pubitemid 46556667)
19. Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R. Projected cost-effectiveness of rotavirus vaccination for children in Asia. J Infect Dis 2005; 192(Suppl 1):S133-45.
20. World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2004. Geneva: World Health Organization, 2004.
21. Bresee J, Fang ZY, Wang B, et al. First report from the Asian Rotavirus Surveillance Network. Emerg Infect Dis 2004; 10:988-995 (Pubitemid 38697688)
22. Tate J, Rheingans R, OReilly CE, et al. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya. Atlanta: Centers for Disease Control and Prevention, 2009:28.
23. Rodrigues A, Aaby P, Molbak K, Fischer TK. Rotavirus disease in Guinea-Bissau, West Africa: a review of longitudinal community and hospital studies. J Infect Dis (in press).
24. Fischer TK, Anh DD, Antil L, et al. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam. J Infect Dis 2005; 192:1720-1726 (Pubitemid 41587821) (Pubitemid 41587821)